BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35322804)

  • 21. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
    Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values.
    Li M; Cheng WT; Li H; Zhang Z; Lu XL; Deng SS; Li J; Yang CH
    Curr Med Sci; 2021 Oct; 41(5):916-929. PubMed ID: 34671904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
    Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
    Front Immunol; 2022; 13():992266. PubMed ID: 36405691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of prognostic ferroptosis-related subtypes classification and hub genes of sepsis.
    Ding N; Xu X; Wang Y; Li H; Cao Y; Zheng L
    Transpl Immunol; 2022 Oct; 74():101660. PubMed ID: 35787932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
    Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
    Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.
    Wang Y; Fan J; Chen T; Xu L; Liu P; Xiao L; Wu T; Zhou Q; Zheng Q; Liu C; Chan FL; Wu D
    Front Endocrinol (Lausanne); 2022; 13():975623. PubMed ID: 36034466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic value of ferroptosis-related genes in patients with Myelodysplastic neoplasms.
    Chen X; Li C; Wang Y; Geng S; Xiao M; Zeng L; Deng C; Li M; Huang X; Weng J; Du X; Lai P
    Hematology; 2023 Dec; 28(1):2288475. PubMed ID: 38038045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of ferroptosis-related genes and their methylation in AML.
    Zhou F; Chen B
    Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma.
    Wang J; Gong M; Xiong Z; Zhao Y; Xing D
    J Orthop Surg Res; 2021 Jul; 16(1):432. PubMed ID: 34225733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis.
    Chen X; Zhang N; Zheng Y; Tong Z; Yang T; Kang X; He Y; Dong L
    Comput Math Methods Med; 2022; 2022():7549894. PubMed ID: 35075370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.
    Niu F; Zhao S; Xu CY; Chen L; Ye L; Bi GB; Tian G; Gong P; Nie TH
    Asian Pac J Cancer Prev; 2014; 15(24):10797-801. PubMed ID: 25605179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel ferroptosis-related gene signature to predict overall survival in patients with osteosarcoma.
    Li J; Wu F; Xiao X; Su L; Guo X; Yao J; Zhu H
    Am J Transl Res; 2022; 14(9):6082-6094. PubMed ID: 36247280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma.
    Chen M; Jiang Y; Sun Y
    Biochem Biophys Res Commun; 2021 Apr; 550():77-83. PubMed ID: 33689883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.